156 related articles for article (PubMed ID: 9137379)
1. [Severe methicillin-resistant Staphylococcus aureus infections. Emergence of resistance to fusidic acid or fosfomycin during treatment with continuous infusion of vancomycin].
Georges B; Brown L; Mazerolles M; Decun JF; Cougot P; Archambaud M; Suc C; Andrieu P; Virenque C
Presse Med; 1997 Apr; 26(11):502-6. PubMed ID: 9137379
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of penicillin G, flucloxacillin, cefazolin, fusidic acid, vancomycin, rifampicin and fosfomycin in muscular infections in mice due to Staphylococcus aureus.
Haag R
Infection; 1986; 14(1):38-43. PubMed ID: 3957435
[TBL] [Abstract][Full Text] [Related]
3. Successful treatment of disseminated methicillin-resistant Staphylococcus aureus with fosfomycin, cefoperazone/sulbactam and rifampin followed by fusidic acid and rifampin.
Apisarnthanarak A; Mundy LM
Int J Infect Dis; 2007 May; 11(3):283-4. PubMed ID: 16876452
[No Abstract] [Full Text] [Related]
4. Monitoring of vancomycin serum levels for the treatment of staphylococcal infections.
Kitzis MD; Goldstein FW
Clin Microbiol Infect; 2006 Jan; 12(1):92-5. PubMed ID: 16460555
[TBL] [Abstract][Full Text] [Related]
5. Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: microbiological and clinical features.
Denis O; Nonhoff C; Byl B; Knoop C; Bobin-Dubreux S; Struelens MJ
J Antimicrob Chemother; 2002 Sep; 50(3):383-91. PubMed ID: 12205063
[TBL] [Abstract][Full Text] [Related]
6. [Severe infections caused by methicillin-resistant Staphylococcus aureus. 62 cases].
May T; Janbon F; Beuscart C; Meyran M; Roue R
Presse Med; 1993 May; 22(19):909-13. PubMed ID: 8378281
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of fosfomycin plus imipenem as rescue therapy for complicated bacteremia and endocarditis due to methicillin-resistant Staphylococcus aureus: a multicenter clinical trial.
del Río A; Gasch O; Moreno A; Peña C; Cuquet J; Soy D; Mestres CA; Suárez C; Pare JC; Tubau F; Garcia de la Mària C; Marco F; Carratalà J; Gatell JM; Gudiol F; Miró JM;
Clin Infect Dis; 2014 Oct; 59(8):1105-12. PubMed ID: 25048851
[TBL] [Abstract][Full Text] [Related]
8. Successful management of methicillin-resistant Staphylococcus aureus bacteremia unresponsive to Vancomycin by adding fosfomycin: a case report.
Linasmita P
J Med Assoc Thai; 2012 Jul; 95(7):960-3. PubMed ID: 22919993
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of two old antibiotics against clinical isolates of methicillin-resistant Staphylococcus aureus.
Yu XH; Song XJ; Cai Y; Liang BB; Lin DF; Wang R
J Antibiot (Tokyo); 2010 Nov; 63(11):657-9. PubMed ID: 20877368
[TBL] [Abstract][Full Text] [Related]
10. [A patient with acute leukemia and meningitis caused by Staphylococcus epidermidis treated with fosfomycin].
Silbermann MH; Gyssens IC; Wielenga JJ; Endtz HP; Löwenberg B
Ned Tijdschr Geneeskd; 1995 Dec; 139(48):2498-501. PubMed ID: 8532088
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of fosfomycin + vancomycin or gentamicin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus (MRSA).
Olay T; Vicente MV; Rodríguez A
J Chemother; 1989 Jul; 1(4 Suppl):391-2. PubMed ID: 16312454
[No Abstract] [Full Text] [Related]
12. Combination chemotherapy for infections due to methicillin-resistant Staphylococcus aureus with combination therapy by cefuzonam and fosfomycin or minocycline in the urologic field.
Matsumoto T; Kubo S; Haraoka M; Takahashi K; Tanaka M; Sakumoto M; Kumazawa J
Clin Ther; 1993; 15(5):819-28. PubMed ID: 8269448
[TBL] [Abstract][Full Text] [Related]
13. [Are we being threatened by multiresistant strains of Staphylococcus aureus?].
Aepfelbacher M
MMW Fortschr Med; 2005 Jan; 147(4):33-5, 37. PubMed ID: 15745339
[TBL] [Abstract][Full Text] [Related]
14. Effect of vancomycin therapy for osteomyelitis on colonization by methicillin-resistant Staphylococcus aureus: lack of emergence of glycopeptide resistance.
Bernard L; Vaudaux P; Vuagnat A; Stern R; Rohner P; Pittet D; Schrenzel J; Hoffmeyer P;
Infect Control Hosp Epidemiol; 2003 Sep; 24(9):650-4. PubMed ID: 14510246
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of the mutant prevention concentrations of vancomycin alone and in combination with levofloxacin, rifampicin and fosfomycin against methicillin-resistant Staphylococcus epidermidis.
Liu LG; Zhu YL; Hu LF; Cheng J; Ye Y; Li JB
J Antibiot (Tokyo); 2013 Dec; 66(12):709-12. PubMed ID: 23981959
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo study of fosfomycin in methicillin-resistant Staphylococcus aureus septicaemia.
Lau WY; Teoh-Chan CH; Fan ST; Lau KF
J Hyg (Lond); 1986 Jun; 96(3):419-23. PubMed ID: 3637200
[TBL] [Abstract][Full Text] [Related]
17. Comparison of continuous infusion versus intermittent infusion of vancomycin in patients with methicillin-resistant Staphylococcus aureus.
Jaruratanasirikul S; Julamanee J; Sudsai T; Saengsuwan P; Jullangkoon M; Ingviya N; Jarumanokul R
J Med Assoc Thai; 2010 Feb; 93(2):172-6. PubMed ID: 20301996
[TBL] [Abstract][Full Text] [Related]
18. [Treatment with arbekacin of surgical infections by resistant strains of Staphylococcus aureus. Arbekacin Study Group].
Morimoto K; Nakatani S; Kaji M; Kinoshita H; Fujimoto M; Hirata S; Ueda T; Tamate S; Yamazaki O
Jpn J Antibiot; 1994 Jun; 47(6):826-36. PubMed ID: 8072193
[TBL] [Abstract][Full Text] [Related]
19. Combined therapy with arbekacin and fosfomycin for methicillin-resistant Staphylococcus aureus infections.
Kono K; Takeda S; Tatara I; Arakawa K; Tanaka H; Miyake S; Minamikawa H; Hoshino H; Sato M; Hattori F
Jpn J Antibiot; 1994 Jun; 47(6):798-803. PubMed ID: 8072189
[TBL] [Abstract][Full Text] [Related]
20. Fusidic acid alone or in combination with vancomycin for therapy of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
Fantin B; Leclercq R; Duval J; Carbon C
Antimicrob Agents Chemother; 1993 Nov; 37(11):2466-9. PubMed ID: 8285635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]